Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Gp VI Llc Orbimed currently holds 5,806,670 shares of 89bio, Inc. (ETNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp VI Llc Orbimed has been a net seller of ETNB stock. They have purchased $45.7M and sold $276.3M worth of shares.
Capital Gp VI Llc Orbimed's most recent insider trade was on Aug 13, 2024, when they purchased 478,342 shares at $4.00 per share.
Capital Gp VI Llc Orbimed serves as Executive at 89bio, Inc. (ETNB). They have executed 68 insider transactions totaling $321.9M over their tenure at the company.
Capital Gp VI Llc Orbimed holds the position of Executive at 89bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Capital Gp VI Llc Orbimed has shown a selling trading pattern, with $45.7M in total purchases and $276.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Capital Gp VI Llc Orbimed was on Mar 1, 2021, when they sold $101.5M worth of SWTX shares. This transaction involved 1,220,000 shares at $83.19 per share.
Capital Gp VI Llc Orbimed currently owns 5,806,670 shares of 89bio, Inc. (ETNB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Gp VI Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Gp VI Llc Orbimed has 68 Form 4 filings on record as an insider at 89bio, Inc..
Set alerts for Capital Gp VI Llc Orbimed and 40,000+ other insiders.